Zobrazeno 1 - 10
of 254
pro vyhledávání: '"B C, Tilley"'
Autor:
Zhang, Guanyu1 (AUTHOR) 1601466858@qq.com, Zhang, Shuo2 (AUTHOR), Zhao, Zhenzhen3 (AUTHOR), Ma, Jinghong4 (AUTHOR), Chan, Piu5 (AUTHOR), Ye, Zheng6 (AUTHOR)
Publikováno v:
Brain & Behavior. Dec2024, Vol. 14 Issue 12, p1-7. 7p.
Autor:
Berendse, Stijn1 (AUTHOR), Krabbe, Johannes2 (AUTHOR), Klaus, Jonas3 (AUTHOR), Ahmed, Faizan1 (AUTHOR) faizan.ahmed@utwente.nl
Publikováno v:
Applied Artificial Intelligence. 2024, Vol. 38 Issue 1, p1-44. 44p.
Publikováno v:
Transplantation Proceedings. 36:3212-3219
As bone marrow transplantation (BMT) increases, the availability of suitable donors becomes critical, especially for African Americans, who require a large donor pool to find a suitable match. Previous studies indicated willingness to donate marrow m
Autor:
Loenneker HD; Department of Psychology, University of Tuebingen, Tuebingen, Germany., Artemenko C; Department of Psychology, University of Tuebingen, Tuebingen, Germany.; LEAD Graduate School & Research Network, University of Tuebingen, Tuebingen, Germany., Willmes K; Department of Neurology, RWTH Aachen University, University Hospital, Aachen, Germany., Liepelt-Scarfone I; Department of Clinical Neurodegeneration, Hertie Institute for Clinical Brain Research, Tuebingen, Germany.; German Centre for Neurodegenerative Diseases, Tuebingen, Germany.; IB-Hochschule für Gesundheit und Soziales, Stuttgart, Germany., Nuerk HC; Department of Psychology, University of Tuebingen, Tuebingen, Germany.; LEAD Graduate School & Research Network, University of Tuebingen, Tuebingen, Germany.; German Center for Mental Health, Tübingen, Germany.
Publikováno v:
Journal of neuroscience research [J Neurosci Res] 2024 Nov; Vol. 102 (11), pp. e25397.
Autor:
E. C. Haley, C. A. Lewandowski, John R. Marler, T. G. Brott, M. Lu, J. C. Grotta, P. C. Lyden, Joseph P. Broderick, S. H. Horowitz, T. P. Kwiatkowski, B. C. Tilley, Steven R. Levine, M. P. Frankel
Publikováno v:
Neurology. 55:1649-1655
Background: The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study showed a similar percentage of intracranial hemorrhage and good outcome in patients 3 months after stroke treatment given 0 to 90 minutes and 91 to 180
Autor:
Chen, Keke1 (AUTHOR), Wang, Songjian2,3 (AUTHOR), Wen, Qiping4 (AUTHOR), Jin, Zhaohui1 (AUTHOR), Wang, Yixuan1 (AUTHOR), Meng, Detao1 (AUTHOR), Yu, Xin5 (AUTHOR), Wang, Mengyue3 (AUTHOR), Lin, Meng3 (AUTHOR), Li, Youwei4 (AUTHOR), Li, Chunlin3 (AUTHOR) lichunlin1981@163.com, Fang, Boyan1 (AUTHOR) fangboyanv@163.com
Publikováno v:
Brain & Behavior. Oct2024, Vol. 14 Issue 10, p1-12. 12p.
Publikováno v:
Journal Club AINS. 4:64-64
Seit der PROMMTT-Studie gibt es Hinweise auf einen moglichen Nutzen des Transfusionsverhaltnisses 1 : 1 : 1 (Plasma, Thrombozyten, EK) gegenuber 1 : 1 : 2, die beide einen Grosteil der klinischen Transfusionspraxis in Nordamerika ausmachen. Eine mogl
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 10(1)
Risk perception may be an important motivator of health-related behaviors. To develop effective risk communication messages, it is important to understand both the patterns of association between perceived risk and health-related behaviors as well as
Publikováno v:
Arthritis and rheumatism. 42(9)
To evaluate global statistical tests (GSTs) of treatment effectiveness for rheumatoid arthritis (RA) trials measuring multiple outcomes.Using outcome measures from American College of Rheumatology (ACR) core set variables available in 3 RA trials, GS
Autor:
T G, Kwiatkowski, R B, Libman, M, Frankel, B C, Tilley, L B, Morgenstern, M, Lu, J P, Broderick, C A, Lewandowski, J R, Marler, S R, Levine, T, Brott
Publikováno v:
The New England journal of medicine. 340(23)
In 1995, the two-part National Institute of Neurological Disorders and Stroke (NINDS) Recombinant Tissue Plasminogen Activator Stroke Trial found that patients who were treated with tissue plasminogen activator (t-PA) within three hours after the ons